Vericiguat was recently PBS-listed as add-on therapy to treat selected patients with chronic heart failure. Who should receive vericiguat and what should you look out for?
Weakness of the legs with sudden onset poses significant concern to the patient and their attending GP, requiring a methodical approach to diagnosis. Urgent investigation and management of red-flag features is essential.
Intestinal failure (IF) is characterised by the inability to maintain nutritional or hydration status via digestive absorption. Patients with chronic IF require parenteral support with either intravenous fluid or parenteral nutrition to maintain life. Management of patients in specialist IF units with expertise in treating this condition can vastly improve the quality and longevity of life.
